Influence of late treatment on how chronic myeloid leukemia responds to imatinib

Influence of late treatment on how chronic myeloid leukemia responds to imatinib

INTRODUCTION: In Brazil, patients with chronic myeloid leukemia (CML) in the chronic phase were not given first-line imatinib treatment until 2008. Therefore, there was a long period of time between diagnosis and the initiation of imatinib therapy for many patients. This study aims to compare the ma...

Full description

Bibliographic Details
Main Authors: Ana Carolina Costa Scerni, Leonardo Azevedo Alvares, Ana Cristina Beltrão, Iê Regina Bentes, Tereza Cristina Azevedo, Alessandra Quinto Bentes, José Alexandre Rodrigues Lemos
Format: Article
Language:English
Published: Elsevier España 2009-01-01
Series:Clinics
Subjects:
CML
BCR-ABL
Imatinib
major molecular remission
late treatment
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322009000800004

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322009000800004

Similar Items